Ridge Biotechnologies is an AI-driven biotechnology company that designs precision enzymes, linkers, and targeted therapeutics.
Ridge Biotechnologies has raised $13.0M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Ridge Biotechnologies's investors include Dimension Capital, Sutter Hill Ventures, Overlap Holdings.
Ridge Biotechnologies is headquartered in Palo Alto, United States.
Ridge Biotechnologies is an AI-driven biotechnology company that designs precision enzymes, linkers, and targeted therapeutics.
Ridge Biotechnologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ridge Biotechnologies — Funding & Investors." VCBacked, September 9, 2026, https://www.vcbacked.co/company/ridge-biotechnologies. Accessed October 30, 2026.
VCBacked. (2026). Ridge Biotechnologies — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/ridge-biotechnologies
{{cite web |title=Ridge Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/ridge-biotechnologies |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated